Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GPCR |
---|---|---|
09:32 ET | 21784 | 37.635 |
09:34 ET | 2911 | 37.765 |
09:36 ET | 3081 | 37.85 |
09:38 ET | 11747 | 37.505 |
09:39 ET | 26916 | 36.945 |
09:41 ET | 1200 | 37.005 |
09:43 ET | 4185 | 36.7678 |
09:45 ET | 13649 | 36.535 |
09:48 ET | 2193 | 36.8278 |
09:50 ET | 2096 | 37.02 |
09:52 ET | 10760 | 37.42 |
09:54 ET | 706 | 37.5 |
09:56 ET | 1000 | 37.445 |
09:57 ET | 625 | 37.35 |
09:59 ET | 4009 | 37.45 |
10:01 ET | 950 | 37.52 |
10:03 ET | 21369 | 37.92 |
10:06 ET | 600 | 37.73 |
10:08 ET | 335 | 37.79 |
10:10 ET | 1770 | 37.685 |
10:12 ET | 1346 | 37.6 |
10:14 ET | 2591 | 37.57 |
10:15 ET | 1940 | 37.57 |
10:17 ET | 500 | 37.52 |
10:19 ET | 371 | 37.33 |
10:21 ET | 400 | 37.664 |
10:24 ET | 345 | 37.535 |
10:26 ET | 1150 | 37.5961 |
10:28 ET | 500 | 37.39 |
10:30 ET | 1500 | 37.41 |
10:32 ET | 1465 | 37.4 |
10:33 ET | 5146 | 37.5 |
10:35 ET | 200 | 37.51 |
10:37 ET | 10962 | 36.987 |
10:39 ET | 11642 | 36.31 |
10:42 ET | 1700 | 36.3 |
10:44 ET | 1258 | 36.565 |
10:46 ET | 5485 | 36.7558 |
10:48 ET | 31457 | 36.785 |
10:50 ET | 500 | 36.731 |
10:51 ET | 800 | 37 |
10:53 ET | 741 | 36.89 |
10:57 ET | 704 | 37.195 |
11:00 ET | 600 | 37.27 |
11:02 ET | 820 | 37.3111 |
11:04 ET | 700 | 37.1 |
11:06 ET | 873 | 37.1 |
11:08 ET | 1148 | 37.16 |
11:09 ET | 3064 | 37.125 |
11:11 ET | 3120 | 37.18 |
11:13 ET | 3377 | 37.45 |
11:15 ET | 1950 | 37.4166 |
11:18 ET | 3120 | 37.445 |
11:20 ET | 2879 | 37.475 |
11:22 ET | 15025 | 37.82 |
11:24 ET | 6587 | 37.9 |
11:26 ET | 400 | 37.99 |
11:27 ET | 7342 | 37.985 |
11:29 ET | 4255 | 37.97 |
11:31 ET | 100 | 37.94 |
11:33 ET | 5111 | 38.1 |
11:36 ET | 2200 | 38.2 |
11:38 ET | 800 | 38.35 |
11:40 ET | 2525 | 38.385 |
11:42 ET | 1402 | 38.435 |
11:44 ET | 8000 | 38.4699 |
11:45 ET | 4829 | 38.255 |
11:47 ET | 1126 | 38.26 |
11:49 ET | 5505 | 38.29 |
11:51 ET | 1164 | 38.25 |
11:54 ET | 755 | 38.23 |
11:56 ET | 5083 | 38.16 |
11:58 ET | 130 | 38.2101 |
12:00 ET | 902 | 38.21 |
12:02 ET | 100 | 38.21 |
12:03 ET | 600 | 38.145 |
12:05 ET | 1045 | 38.185 |
12:07 ET | 400 | 38.185 |
12:09 ET | 699 | 38.185 |
12:12 ET | 2869 | 38.25 |
12:14 ET | 3615 | 38.2 |
12:16 ET | 200 | 38.28 |
12:18 ET | 100 | 38.19 |
12:20 ET | 690 | 38.19 |
12:21 ET | 449 | 38.18 |
12:23 ET | 1709 | 38.135 |
12:25 ET | 1057 | 38.1 |
12:27 ET | 1100 | 38.01 |
12:30 ET | 2300 | 38.01 |
12:32 ET | 1513 | 37.935 |
12:34 ET | 200 | 37.86 |
12:36 ET | 329 | 37.91 |
12:38 ET | 12601 | 37.94 |
12:39 ET | 13725 | 37.55 |
12:41 ET | 2350 | 37.52 |
12:45 ET | 1528 | 37.51 |
12:48 ET | 852 | 37.555 |
12:50 ET | 2419 | 37.6499 |
12:52 ET | 400 | 37.59 |
12:54 ET | 294 | 37.66 |
12:57 ET | 1700 | 37.55 |
12:59 ET | 400 | 37.53 |
01:01 ET | 900 | 37.64 |
01:03 ET | 680 | 37.675 |
01:08 ET | 31462 | 37.925 |
01:10 ET | 5051 | 37.75 |
01:12 ET | 500 | 37.725 |
01:14 ET | 650 | 37.71 |
01:15 ET | 253 | 37.76 |
01:17 ET | 100 | 37.83 |
01:19 ET | 208 | 37.83 |
01:21 ET | 322 | 37.915 |
01:24 ET | 58695 | 37.91 |
01:26 ET | 349 | 37.83 |
01:28 ET | 1411 | 37.9 |
01:30 ET | 1025 | 37.85 |
01:32 ET | 200 | 37.885 |
01:33 ET | 1119 | 37.803 |
01:35 ET | 983 | 37.62 |
01:37 ET | 670 | 37.48 |
01:39 ET | 300 | 37.56 |
01:42 ET | 100 | 37.495 |
01:44 ET | 100 | 37.46 |
01:46 ET | 1600 | 37.4375 |
01:48 ET | 1752 | 37.345 |
01:50 ET | 200 | 37.305 |
01:51 ET | 522 | 37.195 |
01:53 ET | 3674 | 37.3 |
01:55 ET | 6294 | 37.26 |
01:57 ET | 100 | 37.28 |
02:00 ET | 713 | 37.4899 |
02:02 ET | 502 | 37.35 |
02:04 ET | 1352 | 37.15 |
02:06 ET | 1600 | 37.25 |
02:09 ET | 2151 | 37.13 |
02:11 ET | 350 | 37.1 |
02:13 ET | 3532 | 36.9799 |
02:15 ET | 1000 | 36.72 |
02:18 ET | 2200 | 36.79 |
02:20 ET | 411 | 36.9105 |
02:22 ET | 250 | 36.85 |
02:24 ET | 200 | 36.78 |
02:26 ET | 24236 | 36.34 |
02:27 ET | 6067 | 36.18 |
02:29 ET | 672 | 36.11 |
02:31 ET | 16533 | 35.885 |
02:33 ET | 1525 | 35.9 |
02:36 ET | 2650 | 36.04 |
02:38 ET | 1100 | 36.1745 |
02:40 ET | 607 | 36.06 |
02:42 ET | 1805 | 36.145 |
02:44 ET | 1100 | 36.1 |
02:45 ET | 955 | 36.1 |
02:47 ET | 1400 | 36.25 |
02:49 ET | 1100 | 36.54 |
02:51 ET | 300 | 36.57 |
02:54 ET | 900 | 36.49 |
02:58 ET | 500 | 36.42 |
03:00 ET | 200 | 36.32 |
03:02 ET | 807 | 36.495 |
03:03 ET | 1750 | 36.66 |
03:07 ET | 1400 | 36.86 |
03:09 ET | 1600 | 36.91 |
03:12 ET | 1434 | 36.84 |
03:14 ET | 1432 | 36.64 |
03:16 ET | 400 | 36.64 |
03:18 ET | 900 | 36.59 |
03:20 ET | 2288 | 36.55 |
03:21 ET | 100 | 36.62 |
03:23 ET | 200 | 36.61 |
03:25 ET | 1300 | 36.66 |
03:27 ET | 100 | 36.67 |
03:30 ET | 1907 | 36.56 |
03:32 ET | 700 | 36.49 |
03:34 ET | 4153 | 36.484 |
03:36 ET | 4595 | 36.4 |
03:38 ET | 3072 | 36.34 |
03:39 ET | 300 | 36.34 |
03:41 ET | 35007 | 36.5659 |
03:43 ET | 5800 | 36.5 |
03:45 ET | 3829 | 36.21 |
03:48 ET | 742 | 36.16 |
03:50 ET | 7651 | 36.165 |
03:52 ET | 3302 | 36.215 |
03:54 ET | 2764 | 36.34 |
03:56 ET | 4279 | 36.46 |
03:57 ET | 3063 | 36.37 |
03:59 ET | 18247 | 36.38 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Structure Therapeutics Inc | 1.7B | -15.7x | --- |
Edgewise Therapeutics Inc | 1.7B | -11.8x | --- |
Kura Oncology Inc | 1.7B | -10.4x | --- |
Syndax Pharmaceuticals Inc | 1.8B | -6.4x | --- |
Inhibrx Inc | 1.8B | -6.4x | --- |
Sana Biotechnology Inc | 1.8B | -5.4x | --- |
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.7B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 46.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.32 |
Book Value | $9.76 |
P/E Ratio | -15.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.